These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

482 related items for PubMed ID: 6470486

  • 21. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL, Monahan JB, Brickner A, Sodetz JM.
    Biochemistry; 1984 Aug 28; 23(18):4016-22. PubMed ID: 6487588
    [Abstract] [Full Text] [Related]

  • 22. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
    Hänsch GM, Schönermark S, Roelcke D.
    J Clin Invest; 1987 Jul 28; 80(1):7-12. PubMed ID: 3597779
    [Abstract] [Full Text] [Related]

  • 23. Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.
    Packman CH, Rosenfeld SI, Jenkins DE, Thiem PA, Leddy JP.
    J Clin Invest; 1979 Aug 28; 64(2):428-33. PubMed ID: 457861
    [Abstract] [Full Text] [Related]

  • 24. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH, Abramovitz AS, Mayer MM.
    J Immunol; 1976 Sep 28; 117(3):830-4. PubMed ID: 956655
    [Abstract] [Full Text] [Related]

  • 25. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK, Johnson RC, Dalmasso AP.
    J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266
    [Abstract] [Full Text] [Related]

  • 26. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
    Hänsch GM, Hammer CH, Vanguri P, Shin ML.
    Proc Natl Acad Sci U S A; 1981 Aug 01; 78(8):5118-21. PubMed ID: 6946459
    [Abstract] [Full Text] [Related]

  • 27. Elimination of terminal complement intermediates from the plasma membrane of nucleated cells: the rate of disappearance differs for cells carrying C5b-7 or C5b-8 or a mixture of C5b-8 with a limited number of C5b-9.
    Carney DF, Koski CL, Shin ML.
    J Immunol; 1985 Mar 01; 134(3):1804-9. PubMed ID: 3968432
    [Abstract] [Full Text] [Related]

  • 28. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
    Schönermark S, Rauterberg EW, Shin ML, Löke S, Roelcke D, Hänsch GM.
    J Immunol; 1986 Mar 01; 136(5):1772-6. PubMed ID: 2419413
    [Abstract] [Full Text] [Related]

  • 29. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH, Hänsch G, Gresham HD, Shin ML.
    J Immunol; 1983 Aug 01; 131(2):892-8. PubMed ID: 6863934
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Complement pores in erythrocyte membranes. Analysis of C8/C9 binding required for functional membrane damage.
    Sims PJ.
    Biochim Biophys Acta; 1983 Aug 10; 732(3):541-52. PubMed ID: 6871214
    [Abstract] [Full Text] [Related]

  • 33. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
    Husler T, Lockert DH, Sims PJ.
    Biochemistry; 1996 Mar 12; 35(10):3263-9. PubMed ID: 8605162
    [Abstract] [Full Text] [Related]

  • 34. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T, Meri S.
    J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959
    [Abstract] [Full Text] [Related]

  • 35. Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel.
    Boyle MD, Langone JJ, Borsos T.
    J Immunol; 1978 May 01; 120(5):1721-25. PubMed ID: 659873
    [Abstract] [Full Text] [Related]

  • 36. Restriction of cell lysis by homologous complement: II. Protection of erythrocytes against lysis by newly activated complement.
    Houle JJ, Hoffmann EM, Esser AF.
    Blood; 1988 Feb 01; 71(2):287-92. PubMed ID: 3337897
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.